GLP-1 recall: Mounjaro, Zepbound ingredient risk raised to second-highest level

Published on: 10/20/2026

This news was posted by Oregon Today News

Description

Apothecary Pharma LLC. issued a voluntary recall of nearly two dozen lots of Tirzepatide injections due to sterility concerns, with the FDA classifying the risk as Class II — low but not obsolete.

A nationwide recall is being issued for the active ingredient behind mega-popular GLP-1 medications, Mounjaro and Zepbound.

News Source : https://www.oregonlive.com/nation/2026/10/glp-1-recall-mounjaro-zepbound-ingredient-risk-raised-to-second-highest-level.html

Other Related News

The 2026-27 NBA season kicks off this week. Here's how to watch.

10/20/2026

The 2026-27 NBA season kicks off this week Heres how to watch

TikTok staff raised child safety alarms. Court records show executives failed to act

10/20/2026

TikTok employees repeatedly raised concerns internally about the risks the short-form vide...

U.S. to certify Boeing's largest 737 Max after years of delays, source tells AP

10/20/2026

The US government is set to announce the certification of Boeings 737 Max 10 jet Tuesday a...

Congratulations, BHHS Students of the Month for September 2026. The theme of this month was Perseverance! Freshman Jari...

10/20/2026

Congratulations BHHS Students of the Month for September 2026 The theme of this month was ...

Friends Not Bullies Salmon Run Golf CourseA Ghoulish Good Time 👻

10/20/2026

Description

Other Related News

The 2026-27 NBA season kicks off this week Heres how to watch

TikTok employees repeatedly raised concerns internally about the risks the short-form vide...

The US government is set to announce the certification of Boeings 737 Max 10 jet Tuesday a...

Congratulations BHHS Students of the Month for September 2026 The theme of this month was ...

Friends Not Bullies Salmon Run Golf CourseA Ghoulish Good Time

Support

Legal

Follow

Download Our App